Heart Test Laboratories Inc (HSCS)

$3.24 -0.13 (-3.86%)
Market Cap 2.27M
Revenue (ttm) 20,000.00
Net Income (ttm) -6.61M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 11,938
Avg Vol 455,542
Day's Range N/A - N/A
Shares Out 656,000.00
Stochastic %K 24%
Beta 3.16
Analysts Strong Sell
Price Target $13.50

Company Profile

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventi...

Industry: Medical Devices
Sector: Healthcare
Phone: 682 237 7781
Address:
550 Reserve Street, Suite 360, Southlake, United States
supplySHOCK
supplySHOCK Jun. 4 at 10:36 AM
$WFF $GITS $VNRX $HSCS info
0 · Reply
Joe_088
Joe_088 Jun. 3 at 6:50 PM
$HSCS buy and hold 2026 📈⏳5$ plus
1 · Reply
TheUnmaker
TheUnmaker Jun. 2 at 9:07 PM
$TNXP I want to see back over $12.85 tomorrow! $HSCS $QSI $CCCC $SLS BULLISH AF!!
1 · Reply
JackSch
JackSch Jun. 2 at 7:00 PM
$CCCC $HSCS $SLS $TNXP the only bottom that is in is your bottom. STFU
0 · Reply
TheUnmaker
TheUnmaker Jun. 2 at 6:45 PM
$TNXP Super strong bottom. It looks like the bottom is in. Lsts see what the week brings. Strong bounce with many short shares returned today! $HSCS $SLS $CCCC
0 · Reply
DrTampa
DrTampa Jun. 2 at 5:21 PM
$HSCS I don't know about y'all but my tiny tits are jacked 🫡🫡 Now let's see FDA clearance, more contract announcements, and revenue forecasts! https://ir.heartsciences.com/release?i=166877
0 · Reply
Joe_088
Joe_088 Jun. 2 at 3:42 PM
$ELAB $VIDA $HSCS 📈⏳
0 · Reply
Joe_088
Joe_088 Jun. 2 at 3:26 PM
$HSCS Let’s break 2.3
0 · Reply
Jimesica
Jimesica Jun. 2 at 2:47 PM
$HSCS This is a great step in the right direction. They have a product to sell on the market. When their algorithms get FDA approved this should really move along with new customers announcements.
1 · Reply
Joe_088
Joe_088 Jun. 2 at 1:48 PM
$HSCS 📈
0 · Reply
Latest News on HSCS
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

Jun 2, 2026, 8:30 AM EDT - 2 days ago

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

HeartSciences enters commercial agreement with North Shore Health

2026-05-19T12:51:09.000Z - 16 days ago

HeartSciences enters commercial agreement with North Shore Health

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

May 19, 2026, 8:30 AM EDT - 16 days ago

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

HeartSciences signs MyoVista commercial agreement with St. Vincent Health

2026-05-05T13:47:14.000Z - 4 weeks ago

HeartSciences signs MyoVista commercial agreement with St. Vincent Health

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

May 5, 2026, 9:00 AM EDT - 4 weeks ago

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

Apr 14, 2026, 4:15 PM EDT - 7 weeks ago

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Mar 25, 2026, 8:30 AM EDT - 2 months ago

HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

Mar 24, 2026, 11:18 AM EDT - 2 months ago

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Mar 16, 2026, 4:15 PM EDT - 2 months ago

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

HeartSciences announces UWE adopted MyoVista Insights, MyoVista wavECG

2026-02-05T13:47:11.000Z - 4 months ago

HeartSciences announces UWE adopted MyoVista Insights, MyoVista wavECG

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Feb 5, 2026, 8:30 AM EST - 4 months ago

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

HeartSciences MyoVista Insights selected by Cibolo Rural Health Networks

2026-01-29T13:41:04.000Z - 4 months ago

HeartSciences MyoVista Insights selected by Cibolo Rural Health Networks

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Jan 29, 2026, 8:30 AM EST - 4 months ago

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Dec 15, 2025, 4:15 PM EST - 6 months ago

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

HeartSciences announces FDA 510(k) submission for MyoVista wavECG

2025-12-15T13:35:23.000Z - 6 months ago

HeartSciences announces FDA 510(k) submission for MyoVista wavECG

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Dec 15, 2025, 8:30 AM EST - 6 months ago

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

HeartSciences announces commercial release of MyoVista Insights version 1.1

2025-12-11T13:46:02.000Z - 6 months ago

HeartSciences announces commercial release of MyoVista Insights version 1.1

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Dec 11, 2025, 8:30 AM EST - 6 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Sep 11, 2025, 4:15 PM EDT - 9 months ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

HeartSciences Announces Conference Participation and Investor Webinar

Aug 15, 2025, 9:00 AM EDT - 10 months ago

HeartSciences Announces Conference Participation and Investor Webinar

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Jul 24, 2025, 4:15 PM EDT - 11 months ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm

2025-06-04T13:06:22.000Z - 1 year ago

HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Jun 4, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

HeartSciences announces grant by USPTO for ECG assessment of heart function

2025-06-03T13:05:37.000Z - 1 year ago

HeartSciences announces grant by USPTO for ECG assessment of heart function

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

Jun 3, 2025, 9:00 AM EDT - 1 year ago

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

HeartSciences signs first MyoVista Insights platform customer

2025-05-29T13:05:18.000Z - 1 year ago

HeartSciences signs first MyoVista Insights platform customer

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 29, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 20, 2025, 9:00 AM EDT - 1 year ago

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

May 8, 2025, 9:00 AM EDT - 1 year ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

HeartSciences appoints Nadkarni, Lampart, Vai to Scientific Advisory Board

2025-05-07T13:06:44.000Z - 1 year ago

HeartSciences appoints Nadkarni, Lampart, Vai to Scientific Advisory Board

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

May 7, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

HeartSciences launches MyoVista Insights platform

2025-05-01T13:28:48.000Z - 1 year ago

HeartSciences launches MyoVista Insights platform

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

May 1, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 13, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

HeartSciences engages Integrous Communications to enhance communications

2025-03-10T13:10:33.000Z - 1 year ago

HeartSciences engages Integrous Communications to enhance communications

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Mar 10, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Dec 16, 2024, 4:15 PM EST - 1 year ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Heart Test announces CMS included AI-ECG tech in 2025 OPPS final rule

2024-11-13T14:12:03.000Z - 1 year ago

Heart Test announces CMS included AI-ECG tech in 2025 OPPS final rule

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Nov 13, 2024, 9:00 AM EST - 1 year ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 14, 2024, 4:15 PM EDT - 1 year ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Sep 12, 2024, 9:00 AM EDT - 1 year ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

HeartSciences raised $10.3M in proceeds from stock sales , FDA submission close

2024-07-29T20:21:00.000Z - 2 years ago

HeartSciences raised $10.3M in proceeds from stock sales , FDA submission close

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 29, 2024, 4:05 PM EDT - 2 years ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 26, 2024, 9:00 AM EDT - 2 years ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 25, 2024, 8:30 AM EDT - 2 years ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jul 11, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Jun 4, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

May 20, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 24, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

HeartSciences to Present at the LD Micro Invitational XIV Conference

Apr 2, 2024, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 26, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 14, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Mar 6, 2024, 9:00 AM EST - 2 years ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 26, 2024, 9:00 AM EST - 2 years ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

HeartSciences Expands its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 2 years ago

HeartSciences Expands its Scientific Advisory Board

HeartSciences Appoints New Scientific Advisory Board Member

Feb 1, 2024, 9:00 AM EST - 2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Jan 18, 2024, 8:00 AM EST - 2 years ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Jan 3, 2024, 4:15 PM EST - 2 years ago

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Dec 14, 2023, 4:15 PM EST - 2 years ago

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Dec 5, 2023, 8:00 AM EST - 2 years ago

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Nov 13, 2023, 8:45 AM EST - 2 years ago

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Sep 14, 2023, 4:15 PM EDT - 2 years ago

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

supplySHOCK
supplySHOCK Jun. 4 at 10:36 AM
$WFF $GITS $VNRX $HSCS info
0 · Reply
Joe_088
Joe_088 Jun. 3 at 6:50 PM
$HSCS buy and hold 2026 📈⏳5$ plus
1 · Reply
TheUnmaker
TheUnmaker Jun. 2 at 9:07 PM
$TNXP I want to see back over $12.85 tomorrow! $HSCS $QSI $CCCC $SLS BULLISH AF!!
1 · Reply
JackSch
JackSch Jun. 2 at 7:00 PM
$CCCC $HSCS $SLS $TNXP the only bottom that is in is your bottom. STFU
0 · Reply
TheUnmaker
TheUnmaker Jun. 2 at 6:45 PM
$TNXP Super strong bottom. It looks like the bottom is in. Lsts see what the week brings. Strong bounce with many short shares returned today! $HSCS $SLS $CCCC
0 · Reply
DrTampa
DrTampa Jun. 2 at 5:21 PM
$HSCS I don't know about y'all but my tiny tits are jacked 🫡🫡 Now let's see FDA clearance, more contract announcements, and revenue forecasts! https://ir.heartsciences.com/release?i=166877
0 · Reply
Joe_088
Joe_088 Jun. 2 at 3:42 PM
$ELAB $VIDA $HSCS 📈⏳
0 · Reply
Joe_088
Joe_088 Jun. 2 at 3:26 PM
$HSCS Let’s break 2.3
0 · Reply
Jimesica
Jimesica Jun. 2 at 2:47 PM
$HSCS This is a great step in the right direction. They have a product to sell on the market. When their algorithms get FDA approved this should really move along with new customers announcements.
1 · Reply
Joe_088
Joe_088 Jun. 2 at 1:48 PM
$HSCS 📈
0 · Reply
Jimesica
Jimesica Jun. 2 at 1:34 PM
$HSCS https://markets.businessinsider.com/news/stocks/heartsciences-launches-myovista-insights-version-1-3-with-ai-ecg-algorithm-marketplace-and-first-fda-cleared-algorithm-1036217433
0 · Reply
Joe_088
Joe_088 Jun. 2 at 12:43 PM
$HSCS big news low float perfect business📈📈📈📈⏳
0 · Reply
slickinvest
slickinvest Jun. 2 at 12:33 PM
$HSCS 👀
0 · Reply
Stock_Catcher
Stock_Catcher Jun. 2 at 12:30 PM
$HSCS HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
0 · Reply
DrTampa
DrTampa Jun. 2 at 2:08 AM
$HSCS why yes, I will BUY 🤑🤑🫡
0 · Reply
topstockalerts
topstockalerts Jun. 1 at 10:13 PM
$HSCS this one is doing more than most people realize.
1 · Reply
DrTampa
DrTampa Jun. 1 at 7:08 PM
$HSCS Up nearly 30% today, someone knows something not yet publicly known yet and is accumulating... LFG 🫡🤑📈
0 · Reply
TheUnmaker
TheUnmaker Jun. 1 at 5:45 PM
$TNXP Break 12.85 then 13.50 /14.15 LFG! $HSCS $CCCC $SLS
0 · Reply
TheUnmaker
TheUnmaker Jun. 1 at 4:24 PM
$TNXP $HSCS $CCCC $BBLG
0 · Reply
Moneyybaggs
Moneyybaggs Jun. 1 at 11:06 AM
$HSCS Bought 10K more shares Friday. Let’s hope that wasn’t an idiotic/moronic move. Waiting for a substantial PR that causes the stock to move violently upwards. That PR is coming, trust me.
0 · Reply
DrTampa
DrTampa Jun. 1 at 6:17 AM
$HSCS How many of you have been stopped loss's out of your shares? I just keep buying at these prices... NFA, do as you please 🫡
0 · Reply
uddin
uddin May. 29 at 12:54 PM
$HSCS what happened not movement any news ? 🇱🇷🔥
1 · Reply